In This Section

Proven ability to gain competitive advantage in specialty branded markets

Flynn acquired the marketing rights to Product A, a new product for the treatment of ADHD. Flynn created a sales force of healthcare specialist representatives and launched Product A into a competitive market place. The growth of the product has been impressive and consistent since launch versus its competitors (Product B and Product C).

Product A

Market share has increased significantly over the time period.

Product B

Market share has fallen significantly over the time period.

Product C

Market share has remained relatively flat over the time period.

Call us on
+44 (0)1438 727 822
Email Us
office2@flynnpharma.com
Enquire Online
Thank you for letting us use cookies to improve your experience. For more information on the cookies we use see our privacy policy.